PGR

Progressive Corporation

$219.28

-0.48%
Aug 21, 2026
Bobby Quantitative Model
Progressive Corporation is a leading U.S. property and casualty insurer, primarily underwriting private and commercial auto insurance along with specialty lines, and has expanded into homeowners insurance. As one of the largest auto insurers in the country with nearly 27 million personal auto policies in force, it distinguishes itself through a dual distribution model combining independent agencies with direct-to-consumer channels. The current investor narrative centers on the company's robust underwriting discipline and the potential for its substantial float to generate higher investment income in a rising rate environment, while also debating the sustainability of its growth and the reliability of its dividend. Recent news highlights the strength of its underwriting machine and the impact of higher rates on earnings, but also cautions about the stock's valuation and dividend yield.

People also watch

The Travelers Companies

The Travelers Companies

TRV

Analysis
Allstate

Allstate

ALL

Analysis
W. R. Berkley

W. R. Berkley

WRB

Analysis
Cincinnati Financial

Cincinnati Financial

CINF

Analysis
Markel Corporation

Markel Corporation

MKL

Analysis

BobbyInvestment Opinion: Should I buy PGR Today?

Rating: Hold. Progressive is a well-managed insurer with a strong competitive position, but the stock's recent underperformance and cautious analyst sentiment suggest limited near-term upside. The average analyst target of $229.78 implies a 9.6% upside, which is modest given the risks.

Sign up to view all

PGR 12-Month Price Forecast

The AI assessment is neutral, reflecting a balanced risk-reward profile. The stock's low PE and strong fundamentals provide a margin of safety, but the decelerating growth and cautious analyst sentiment limit upside. The key factors suggest that Progressive is fairly valued with moderate growth prospects. An upgrade to bullish would require evidence of accelerating growth or a significant improvement in investment income, while a downgrade would be warranted if margins deteriorate or revenue growth falls below 5%.

Historical Price
Current Price $219.28
Average Target $230.00
High Target $280.00
Low Target $190.00

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Progressive Corporation's 12-month outlook, with a consensus price target around $229.68 and implied upside of +4.7% versus the current price.

Average Target

$229.68

0 analysts

Implied Upside

+4.7%

vs. current price

Analyst Count

covering this stock

Price Range

$198 - $309

Analyst target range

Progressive is covered by 21 analysts, with a consensus recommendation of 'hold' and a mean recommendation score of 2.68 (where 1 is strong buy and 5 is sell). The average target price is $229.78, implying an upside of 9.63% from the current price of $209.60. The distribution of ratings is not provided, but the 'hold' consensus suggests a neutral stance, with some analysts seeing value but others cautious on near-term catalysts. The high target of $308.00 implies a 46.95% upside, likely assuming strong underwriting results and investment income growth, while the low target of $198.00 implies a -5.53% downside, possibly pricing in margin compression or competitive pressures. The wide spread between high and low targets (55.6% of the average) indicates high uncertainty among analysts, which is typical for a stock that has underperformed the market recently. Recent institutional actions show a mix of ratings, with JP Morgan downgrading from Overweight to Neutral in July 2026, while B of A Securities reiterated a Buy in June 2026, suggesting a lack of strong conviction in either direction.

Drowning in data?

Find the real signal!

Bulls vs Bears: PGR Investment Factors

Progressive presents a mixed picture: strong underwriting and a low PE suggest value, but recent underperformance and decelerating growth raise concerns. The bull case rests on the company's ability to leverage its float and maintain margins, while the bear case focuses on competitive pressures and potential earnings headwinds. Currently, the evidence slightly favors the bull case due to the attractive valuation and solid fundamentals, but the stock's relative weakness and analyst caution warrant a balanced approach. The key tension is whether Progressive can sustain its growth and profitability in a competitive market, which will determine if the low PE is a value trap or an opportunity.

Bullish

  • Strong Underwriting Discipline: Progressive's operating margin of 16.2% and net margin of 12.9% demonstrate superior underwriting profitability compared to industry averages. The company's ability to maintain these margins while growing revenue highlights its competitive advantage in pricing and risk selection.
  • Attractive Valuation with Low PE: The trailing PE of 11.8x and forward PE of 12.9x are significantly below the broader market and historical averages for P&C insurers. The PEG ratio of 0.35x suggests the stock is undervalued relative to its expected earnings growth, offering a margin of safety.
  • Beneficiary of Higher Interest Rates: With a $94 billion float, Progressive is poised to generate higher investment income as rates remain elevated. This could boost earnings and partially offset any underwriting cyclicality, providing a tailwind for future profitability.
  • Consistent Revenue Growth: Revenue grew 7.4% YoY in Q2 2026, with a multi-quarter trend of steady increases. The company's scale and brand recognition support continued premium growth, even in a competitive market.

Bearish

  • Underperforming the Market: Progressive's stock has declined 16.5% over the past year, while the S&P 500 gained 20.4%, resulting in a relative underperformance of 36.8%. This suggests investors are concerned about the company's growth prospects or valuation.
  • Decelerating Revenue Growth: Revenue growth slowed from 8.5% in Q1 2026 to 7.4% in Q2 2026, indicating a potential trend of deceleration. If this continues, it could pressure the stock's valuation multiple.
  • High Valuation Relative to Peers: Despite the low PE, the price-to-book ratio of 4.4x is elevated compared to historical norms for P&C insurers. This suggests the market is pricing in strong future returns on equity, which may be optimistic.
  • Dividend Yield Not Compelling: The dividend yield of 2.15% is modest, and the payout ratio of 25.4% indicates limited room for significant increases. Income-focused investors may find better alternatives elsewhere.

PGR Technical Analysis

Progressive's stock has experienced a significant downtrend over the past year, with a 1-year price change of -16.48%, while the S&P 500 gained 20.37% in the same period, resulting in a relative strength of -36.85%. The current price of $209.60 sits at 82.2% of its 52-week range (between $189.20 low and $254.93 high), indicating the stock is closer to the lower end of its range, which could suggest a value opportunity or a falling knife depending on fundamental support. The stock's beta of 0.257 implies it is significantly less volatile than the market, which may appeal to risk-averse investors but also means it has underperformed in a rising market.

Beta

0.26

0.26x market volatility

Max Drawdown

-24.6%

Largest decline past year

52-Week Range

$189-$253

Price range past year

Annual Return

-11.9%

Cumulative gain past year

PeriodPGR ReturnS&P 500
1m+7.2%+2.5%
3m+9.9%+2.7%
6m+7.4%+11.1%
1y-11.9%+20.5%
ytd+3.4%+12.3%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

PGR Fundamental Analysis

Progressive's revenue has been growing steadily, with the most recent quarter (Q2 2026) reporting revenue of $23.617 billion, a 7.37% year-over-year increase from $21.995 billion in Q2 2025. The multi-quarter trend shows consistent growth, with Q1 2026 revenue at $22.18 billion, Q4 2025 at $22.738 billion, and Q3 2025 at $22.512 billion, indicating a deceleration from the 7.37% YoY growth in Q2 2026 compared to the 8.5% growth in Q1 2026 (calculated from $20.402 billion in Q1 2025). The Personal Lines segment dominates, contributing $18.66 billion (79% of total revenue) in the latest quarter, while Commercial Lines contributed $2.603 billion, showing the core driver of growth remains the personal auto insurance business.

Quarterly Revenue

$23.6B

2026-06

Revenue YoY Growth

+7.4%

YoY Comparison

Gross Margin

25.1%

Latest Quarter

Free Cash Flow

$16.4B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Commercial Lines Segment
Personal Lines Segment

Open an Account, get $2 TSLA now!

Valuation Analysis: Is PGR Overvalued?

Given that Progressive's net income is positive, the PE ratio is the primary valuation metric. The trailing PE is 11.81x, while the forward PE is 12.88x, indicating that the market expects earnings to slightly decline or grow slowly, as the forward PE is higher than the trailing. This gap suggests modest growth expectations, which is consistent with the company's mature industry and recent deceleration. The PEG ratio of 0.35x implies that the stock is undervalued relative to its expected earnings growth, but this is based on analyst estimates that may be optimistic.

PE

11.8x

Latest Quarter

vs. Historical

Low-End

5-Year PE Range 10x~58x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

9.5x

Enterprise Value Multiple

Investment Risk Disclosure

Financial risks include the company's reliance on investment income, which is sensitive to interest rate fluctuations. While higher rates benefit the float, a sudden drop could reduce earnings. Additionally, the debt-to-equity ratio of 0.23 is manageable, but the current ratio of 0.59 indicates potential liquidity concerns, though this is typical for insurers. The payout ratio of 25.4% suggests dividend sustainability, but any significant earnings decline could force a cut, disappointing income investors.

FAQ

The key risks include: 1) Competitive pressures in the auto insurance market, which could lead to margin compression and slower growth. 2) Interest rate fluctuations, as a decline would reduce investment income and hurt earnings. 3) Regulatory changes that could impact pricing or underwriting practices. 4) The stock's low beta means it may underperform in strong bull markets, as seen over the past year. The most severe risk is a combination of these factors leading to a significant earnings miss, which could push the stock down to the 52-week low of $189.20.

The 12-month forecast is based on three scenarios: a bull case with a 25% probability, targeting $250-$280; a base case with a 50% probability, targeting $220-$240; and a bear case with a 25% probability, targeting $190-$210. The base case is most likely, assuming steady revenue growth and stable margins, which would bring the stock to around the average analyst target of $229.78. The key assumption is that Progressive can maintain its underwriting discipline and benefit from higher interest rates.

Based on the trailing PE of 11.8x, Progressive appears undervalued relative to the broader market and its own historical average. The PEG ratio of 0.35x further supports this view, indicating that the stock is trading at a discount to its expected growth. However, the price-to-book ratio of 4.4x is elevated, suggesting the market is paying a premium for its strong return on equity. Overall, the stock is fairly valued to slightly undervalued, with the market pricing in modest growth expectations.

Progressive is a good buy for investors seeking a stable, low-beta stock with a reasonable valuation. The trailing PE of 11.8x is below the market average, and the average analyst target of $229.78 implies a 9.6% upside. However, the stock has underperformed the market over the past year, and the consensus rating is 'hold', suggesting limited near-term catalysts. It is best suited for long-term investors who value dividend income and capital preservation over aggressive growth.

Progressive is more suitable for long-term investment due to its low beta, stable earnings, and dividend payments. The stock's volatility is low, making it less attractive for short-term traders seeking quick gains. Over the long term, the company's strong underwriting and potential for investment income growth could drive steady appreciation. A minimum holding period of 3-5 years is recommended to ride out any cyclical downturns and benefit from compounding dividends.